Levin Capital Strategies’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Levin Capital Strategies’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-7,227	Closed	-$287	–	363
2016 Q3	$287	Buy	+7,227	New	+$80.6K	﹤0.01%	270

Levin Capital Strategies's TBRA Position: Q4 2016 in Review

Levin Capital Strategies sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 7,227 shares — an estimated $287 sold.

Levin Capital Strategies first reported a position in TBRA in Q3 2016 and held it in 1 quarter. The position peaked at $287 in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

Levin Capital Strategies reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Levin Capital Strategies sold 7,227 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $287.
Levin Capital Strategies first reported a position in Tobira Therapeutics, Inc. Common Stock in Q3 2016 and held it in 1 quarter.
Levin Capital Strategies's Tobira Therapeutics, Inc. Common Stock position peaked at $287 in Q3 2016.
0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on Levin Capital Strategies's 13F filing for Q4 2016, filed 14 Feb 2017.